Stephen L. Mullennix
Equibles does not estimate personal net worth.
Get an email with a short summary when UroGen Pharma Ltd. publishes a filing, an earnings call transcript or a press release.
Get URGN alertsAbout Stephen L. Mullennix
Stephen L. Mullennix is recorded as COO at UroGen Pharma Ltd. (URGN). The newest filing on record that lists Stephen L. Mullennix as COO at UroGen Pharma Ltd. (URGN) is dated April 28, 2021. The proxy statement of UroGen Pharma Ltd. reports total compensation of $906,376 for Stephen L. Mullennix in fiscal 2020, including a base salary of $139,311. Disclosed compensation is on record for 3 fiscal years. UroGen Pharma Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at UroGen Pharma Ltd. includes Elizabeth Barrett (CEO and Board Member), Arie Belldegrun (Chairman and Board Member), Chris Degnan (CFO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 28, 2021
Company network
Leadership on record at UroGen Pharma Ltd.
- Elizabeth Barrett CEO, Board Member
- Arie Belldegrun Chairman, Board Member
- Chris Degnan CFO
- Dong (Don) Kim CFO
- Jason Smith General Counsel
- Christopher Degnan Chief Accounting Officer
- Arie Belldegrun, M.D. Board Member
- Arie Belldegrun, M.D., FACS Board Member
- Cynthia M. Butitta Board Member
- Daniel G. Wildman Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | UroGen Pharma Ltd. (URGN) | Chief Operating Officer | $139,311 | $906,376 |
| 2019 | UroGen Pharma Ltd. (URGN) | Chief Operating Officer | $435,625 | $1,346,512 |
| 2018 | UroGen Pharma Ltd. (URGN) | Chief Operating Officer | $359,754 | $4,309,568 |
Recent activity
No call appearances or filed executive changes recorded yet.